{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:41:29Z","timestamp":1767145289740,"version":"build-2238731810"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ejogrb.2005.08.019","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T10:19:28Z","timestamp":1127816368000},"page":"251-254","source":"Crossref","is-referenced-by-count":20,"title":["The cyclooxygenase-2 inhibitor rofecoxib (Vioxx\u00ae) in the treatment of cervical dysplasia grade II\u2013III"],"prefix":"10.1016","volume":"125","author":[{"given":"Lukas A.","family":"Hefler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Sliutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Reinthaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.08.019_bib1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","article-title":"Treatment for cervical intraepithelial neoplasia and risk of preterm delivery","volume":"291","author":"Sadler","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib3","first-page":"3356","article-title":"A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix","volume":"7","author":"Follen","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib4","first-page":"1029","article-title":"A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia","volume":"10","author":"Keefe","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.2000.5847","article-title":"Placebo-controlled trial of indole-3-carbinol in the treatment of CIN","volume":"78","author":"Bell","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001703-200502000-00009","article-title":"COX-2: a protein with an active role in gynecological cancers","volume":"17","author":"Munkarah","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0090-8258(03)00224-5","article-title":"Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes","volume":"90","author":"Kim","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2003.10.052","article-title":"Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure","volume":"92","author":"Farley","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib10","unstructured":"Powell MA, Pfeifer JD, Buttin BS, Gibb RK, Luck MB, Rader JS. A pilot study of celecoxib in the treatment of patients with cervical and vaginal neoplasia. Abstract No. 1830, Annual Meeting of ASCO 2003."},{"key":"10.1016\/j.ejogrb.2005.08.019_bib11","unstructured":"Miller BE, Cappellari JO. Cyclooxygenase-2 inhibition for the treatment of cervical intraepithelial neoplasia. Abstract No. 381, Annual Meeting of ASCO 2003."},{"key":"10.1016\/j.ejogrb.2005.08.019_bib12","unstructured":"Preston GG, Farley J, Truong V, Byrnes C, Goo E, Belnap C, Yoshinobu B, Salminen E. A randomized, placebo-controlled evaluation of the cyclooxygenase-2 protein inhibitor celecoxib in treating dysplasia of the cervix: a pilot study. Abstract No. 858 Annual Meeting of ASCO 2003."},{"key":"10.1016\/j.ejogrb.2005.08.019_bib13","first-page":"4324","article-title":"Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study","volume":"9","author":"Ferrandina","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib14","unstructured":"Rader JS (http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00081263?order=3)."},{"key":"10.1016\/j.ejogrb.2005.08.019_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.10888","article-title":"A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia","volume":"103","author":"Barnett","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2005.08.019_bib16","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.ejogrb.2006.05.033","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000}}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:29:25Z","timestamp":1548109765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505004525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0301211505004525"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.08.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}